Comparison

ICL or scleral lenses: which is right for me?

An implantable collamer lens (ICL) is a lens placed inside the eye in surgery. A scleral lens is a large contact lens you put in each morning. They solve different problems, and for many scleral lens wearers only one of them is a real option.

By the Scleral Lens Team · Updated October 5, 2026 · 7 published sources cited

The short answer

They do different jobs. An ICL is a permanent lens implanted inside the eye to correct nearsightedness, with or without regular astigmatism, in adults with a stable prescription and an eye of the right shape. It doesn't smooth out an irregular cornea. A scleral lens sits on the eye's surface, vaults over the cornea, and can correct the blur an irregular cornea causes, at the cost of daily handling. ICLs have been used in some people with stable, milder keratoconus, but that's outside the FDA-approved uses, and the evidence is observational.

Key points

  • An ICL is surgery: a lens placed inside the eye, in front of your natural lens.
  • FDA approval covers nearsighted adults aged 21 to 45 with a stable prescription.
  • An ICL corrects focusing error, not the irregular shape of a cornea.
  • Scleral lenses mask corneal irregularity, need no surgery, and come out daily.
  • In stable keratoconus, ICLs reduce dependence on glasses but evidence is limited.

Two very different lenses

An implantable collamer lens (ICL) is an artificial lens permanently implanted inside the eye. It sits behind the iris and in front of your own natural lens, which stays in place. It bends light so it focuses on the retina, correcting nearsightedness, and the toric version also corrects astigmatism.[1]

A scleral lens is a large rigid contact lens that rests on the white of the eye and vaults over the cornea, with a layer of saline underneath. You put it in each morning and take it out at night. Because the fluid fills in the gaps between the lens and an irregular cornea, it can correct blur that glasses can’t.

The key difference: an ICL corrects a focusing error. A scleral lens can also correct an irregular front surface of the eye.

Who an ICL is approved for

In the US, the current EVO and EVO+ Visian ICL and toric ICL were approved by the FDA in 2022.[1] The FDA-approved labeling says they’re indicated for people aged 21 to 45 who are nearsighted, within set prescription ranges, with a stable prescription for a year before surgery and enough depth in the front chamber of the eye.[2]

The FDA says they should not be used in people who:[1]

  • are pregnant or nursing
  • are younger than 21
  • have moderate to severe glaucoma
  • have a front chamber of the eye that’s too shallow, or a drainage angle that’s too narrow
  • don’t have enough endothelial cells, the single layer of cells on the inside of the cornea that keeps it clear

The labeling also says safety and effectiveness haven’t been established in people with unstable or worsening nearsightedness, a history of previous eye surgery, or a progressive sight-threatening disease other than nearsightedness.[2] That last group can include progressive keratoconus.

ICL risks to know about

The FDA-approved patient booklet lists risks including:[3]

  • Cataract. The risk of a cataract continues to rise with each year the lens is in the eye, and is higher with older age and stronger nearsightedness.
  • Loss of corneal endothelial cells beyond normal aging, which in severe cases can lead to corneal swelling that may need a transplant.
  • Raised eye pressure and glaucoma.
  • Glare and halos, especially in dim light.
  • Further surgery to remove, replace, or reposition the lens.

Regular eye exams for as long as the lens is in place are part of having an ICL.[3]

ICL and keratoconus

Because an ICL doesn’t reshape the cornea, its role in keratoconus is narrower than in ordinary nearsightedness. Surgeons have used ICLs and other phakic implants in stable keratoconus, outside the FDA-approved uses:

  • A 2024 review found no randomized trials, only retrospective and prospective case series. It concluded that phakic implants are a valid option in stable keratoconus with moderate to high prescriptions and regular or mildly irregular astigmatism, and suitable for eyes without advanced keratoconus or highly irregular astigmatism.[5]
  • A 2025 meta-analysis of 16 observational studies (397 eyes) found that ICLs significantly improved uncorrected vision and reduced prescription, but did not significantly improve best-corrected vision. The authors noted the evidence was limited by observational designs and short follow-up.[4]

Put simply, an ICL can reduce how much someone with stable keratoconus depends on glasses, but it doesn’t remove the distortion an irregular cornea causes. That distortion is what scleral lenses are designed to correct. In one study of 157 keratoconus eyes that wore scleral lenses successfully for at least a year, average best-corrected vision improved significantly compared with glasses.[6]

Side by side

ICL Scleral lens
What it is Lens implanted inside the eye Large contact lens on the eye’s surface
Surgery Yes No
Corrects Nearsightedness, regular astigmatism Most prescriptions, plus an irregular cornea
Irregular cornea (keratoconus, transplant) Doesn’t correct the irregularity; used off-label in some stable keratoconus A main use
Dry eye or surface disease Doesn’t treat Can protect the surface
Daily routine None once healed Insert, remove, clean every day
Age FDA-approved for 21 to 45 Children to older adults
Main risks Surgical risks, cataract, endothelial cell loss, raised eye pressure Infection, especially with poor care; handling problems
Reversible Removable with further surgery Stop wearing at any time

Who each tends to suit

An ICL may suit a nearsighted adult with a regular cornea, a stable prescription, and an eye that meets the measurements, who wants to stop wearing glasses or contacts.

Scleral lenses may suit someone whose cornea is irregular from keratoconus, a transplant, previous refractive surgery, or scarring; someone with severe dry eye or surface disease; or someone who wants to avoid eye surgery. They require daily handling, which not everyone manages. See am I a candidate for scleral lenses?

Some people with stable keratoconus are offered combinations, such as cross-linking first, then an implant. See scleral lenses vs cross-linking and scleral lenses vs Intacs.

What to ask

Your surgeon:

  • Is my cornea regular enough that an ICL would give me clear vision?
  • Is my prescription, and my keratoconus if I have it, stable?
  • Do my eye measurements and endothelial cell count meet the requirements?
  • What follow-up will I need, and for how long?

Your scleral lens fitter:

  • Is the blur I have from my prescription or from my cornea’s shape?
  • Would I still need a scleral lens after an ICL?

Common questions

I have keratoconus. Could an ICL replace my scleral lenses?

For some people with stable, milder keratoconus, an ICL can reduce how much they rely on glasses or contact lenses, and it's been studied in that setting. It doesn't fix the irregular cornea itself, so people whose vision is limited by irregularity may still need a scleral lens. This use is outside the FDA-approved indications. Ask a cornea or refractive surgeon who treats keratoconus.

Can I have an ICL and still wear scleral lenses?

Some people do use both, with the ICL handling the prescription and a scleral lens handling an irregular surface or dry eye. Whether that makes sense for you is a question for your surgeon and fitter together.

Is an ICL permanent?

It's designed to stay in the eye, but it can be removed or replaced in another operation. The FDA-approved patient labeling says another surgery may be needed to take out, replace, or reposition the lens, or if a cataract develops.

I had a corneal transplant. Can I get an ICL?

The FDA labeling says the safety and effectiveness of the ICL haven't been established in people with a history of previous eye surgery. That doesn't rule it out for every patient, but it's a specialist decision. Scleral lenses are one option after a transplant: see our corneal transplant condition page.

Which is safer?

They carry different kinds of risk. An ICL carries surgical risks and longer-term risks inside the eye, such as cataract and loss of corneal endothelial cells. A scleral lens carries daily-wear risks, such as infection, especially with poor lens care. A surgeon and fitter can weigh them for your eye.

Keep reading

Scleral lenses vs Intacs and other corneal ring segments

Intacs and other intracorneal ring segments are a surgical option that flattens and regularizes a keratoconic cornea. They can improve vision without correction and with glasses, but many people still need a contact lens afterward. Scleral lenses usually give sharper corrected vision with no surgery, but they're a daily routine. Neither one is designed to stop keratoconus from progressing. Which fits you depends on your cornea, your tolerance for lenses, and your surgeon's and fitter's assessment.

Scleral lenses vs corneal cross-linking

Cross-linking is a procedure that strengthens the cornea to stop keratoconus from progressing. It doesn't usually restore clear vision. Scleral lenses give clear vision, but they don't stop the disease. So they aren't alternatives: if your keratoconus is getting worse, cross-linking is the treatment designed for that, and a scleral lens (or another lens) is how you see well before and after.

Scleral lenses vs corneal transplant

For many people with an irregular cornea, a well-fitted scleral lens gives clear enough vision that a transplant can be delayed or avoided. In one clinic, most eyes with severe keratoconus that would otherwise have been referred for surgery did well in scleral lenses instead. A transplant is still the answer when the cornea is too scarred or cloudy for a lens to help, or when lenses can't be worn. And a transplant doesn't always end lens wear: many people need specialty lenses afterward.

Can scleral lenses help after LASIK?

Yes, for some people. LASIK and other laser surgeries can leave the cornea's surface uneven, which causes halos, ghosting, or blur that glasses can't correct, and they can also cause dry eye. A scleral lens covers the uneven surface with a smooth optical one and bathes the cornea in fluid. In a small study of people with irregular corneas after refractive surgery, vision and dry eye symptoms both improved. If your cornea has started to bulge (ectasia), that is a different problem, covered on its own page.

Am I a candidate for scleral lenses?

You may be a good candidate if glasses or other contact lenses don't give you clear, comfortable vision because your cornea is irregular, or if your eye surface is damaged or very dry. Scleral lenses are less often the right choice for an ordinary prescription on a healthy eye, or when handling a large lens every day isn't realistic. Only an eye examination can tell you for sure, and a good fitter will tell you if another option suits you better.

Sources

  1. U.S. Food and Drug Administration. EVO/EVO+ VISIAN Implantable Collamer Lens, P030016/S035 (Recently-Approved Devices). Approved March 25, 2022. Content current as of April 18, 2022. fda.gov
  2. STAAR Surgical. EVO/EVO+ VISIAN Implantable Collamer Lens for Myopia and EVO/EVO+ VISIAN TORIC Implantable Collamer Lens for Myopia: Directions for Use (FDA-approved labeling, P030016/S035). accessdata.fda.gov
  3. STAAR Surgical. EVO ICL Patient Information Booklet (FDA-approved labeling, P030016/S035). accessdata.fda.gov
  4. Alkhabbaz AA, Karam MH, Pollmann AS, et al. Safety and efficacy of posterior chamber phakic implantable collamer lenses in patients with keratoconus: a systematic review and meta-analysis. Am J Ophthalmol. 2025;271:222-232. doi:10.1016/j.ajo.2024.11.013 pubmed.ncbi.nlm.nih.gov
  5. Nowrouzi A, D'Oria F, Alió Del Barrio JL, Alió JL. Phakic intraocular lens implantation in keratoconus patients. Eur J Ophthalmol. 2024;34(5):1365-1372. doi:10.1177/11206721231199780 pubmed.ncbi.nlm.nih.gov
  6. Fuller DG, Wang Y. Safety and efficacy of scleral lenses for keratoconus. Optom Vis Sci. 2020;97(9):741-748. doi:10.1097/OPX.0000000000001578 pubmed.ncbi.nlm.nih.gov
  7. U.S. Food and Drug Administration. Contact Lens Risks. Content current as of September 4, 2018. fda.gov

Last updated October 5, 2026. Found an error or a newer study? Let us know and we'll correct the page.